Abdel‐Baset Halim

696 total citations
19 papers, 557 citations indexed

About

Abdel‐Baset Halim is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Abdel‐Baset Halim has authored 19 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Abdel‐Baset Halim's work include Meta-analysis and systematic reviews (3 papers), Clinical Laboratory Practices and Quality Control (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Abdel‐Baset Halim is often cited by papers focused on Meta-analysis and systematic reviews (3 papers), Clinical Laboratory Practices and Quality Control (3 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Abdel‐Baset Halim collaborates with scholars based in United States, Germany and Egypt. Abdel‐Baset Halim's co-authors include O. El-Ahmady, Arthur M. Geller, Malak Kotb, Leighton LeGros, Michael A. Gerber, S. Dash, Naoki Hiramatsu, M Samama, Jeanne Mendell and Robert A. Beckman and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Clinical Cancer Research.

In The Last Decade

Abdel‐Baset Halim

19 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abdel‐Baset Halim United States 10 201 117 100 98 96 19 557
Jun Xue China 14 187 0.9× 72 0.6× 41 0.4× 73 0.7× 122 1.3× 45 657
Qifan Zhang China 14 316 1.6× 117 1.0× 157 1.6× 103 1.1× 112 1.2× 44 733
Hiroyuki Muro Japan 16 127 0.6× 114 1.0× 181 1.8× 123 1.3× 69 0.7× 41 687
Jing Quan Lim Singapore 15 242 1.2× 246 2.1× 24 0.2× 45 0.5× 71 0.7× 33 826
Jeanine Ward United States 11 560 2.8× 48 0.4× 146 1.5× 210 2.1× 68 0.7× 16 1.0k
Shinji Furuya Japan 16 167 0.8× 174 1.5× 105 1.1× 136 1.4× 122 1.3× 78 692
Nicola Gentiloni Italy 11 151 0.8× 89 0.8× 32 0.3× 105 1.1× 69 0.7× 15 746
Hidenari Nagai Japan 14 173 0.9× 107 0.9× 308 3.1× 203 2.1× 75 0.8× 76 649
Jiaqi Li China 14 142 0.7× 127 1.1× 30 0.3× 69 0.7× 205 2.1× 41 658

Countries citing papers authored by Abdel‐Baset Halim

Since Specialization
Citations

This map shows the geographic impact of Abdel‐Baset Halim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdel‐Baset Halim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdel‐Baset Halim more than expected).

Fields of papers citing papers by Abdel‐Baset Halim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdel‐Baset Halim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdel‐Baset Halim. The network helps show where Abdel‐Baset Halim may publish in the future.

Co-authorship network of co-authors of Abdel‐Baset Halim

This figure shows the co-authorship network connecting the top 25 collaborators of Abdel‐Baset Halim. A scholar is included among the top collaborators of Abdel‐Baset Halim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdel‐Baset Halim. Abdel‐Baset Halim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Song, SaeHeum, Dongwoo Kang, Abdel‐Baset Halim, & Raymond Miller. (2014). Population pharmacokinetic‐pharmacodynamic modeling analysis of intrinsic FXa and bleeding from edoxaban treatment. The Journal of Clinical Pharmacology. 54(8). 910–916. 21 indexed citations
2.
Halim, Abdel‐Baset, M Samama, & Jeanne Mendell. (2014). Ex vivo reversal of the anticoagulant effects of edoxaban. Thrombosis Research. 134(4). 909–913. 36 indexed citations
3.
LoRusso, Patricia, Pasi A. Jänne, Moacyr Oliveira, et al.. (2013). Phase I Study of U3-1287, a Fully Human Anti-HER3 Monoclonal Antibody, in Patients with Advanced Solid Tumors. Clinical Cancer Research. 19(11). 3078–3087. 74 indexed citations
4.
Halim, Abdel‐Baset. (2013). The biggest challenges currently facing companion diagnostic advancement. Expert Review of Molecular Diagnostics. 14(1). 27–35. 2 indexed citations
5.
Feldman, Darren R., Lawrence H. Einhorn, David I. Quinn, et al.. (2013). A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors. Investigational New Drugs. 31(4). 1016–1022. 39 indexed citations
6.
Halim, Abdel‐Baset. (2013). Proficiency Testing for Monitoring Global Laboratory Performance and Identifying Discordance. Laboratory Medicine. 44(1). e19–e30. 5 indexed citations
7.
Pishvaian, Michael J., John L. Marshall, Andrew J. Wagner, et al.. (2012). A phase 1 study of efatutazone, an oral peroxisome proliferator‐activated receptor gamma agonist, administered to patients with advanced malignancies. Cancer. 118(21). 5403–5413. 60 indexed citations
8.
Zahir, Hamim, Scott J. Rodig, Lecia V. Sequist, et al.. (2012). 482 Relationship Between Tumor MET Expression and Clinical Outcomes in Cancer Patients Treated with Tivantinib. European Journal of Cancer. 48. 149–149. 2 indexed citations
9.
Halim, Abdel‐Baset. (2011). Discrepant Results from Laboratories Impact Patients Receiving Heparin or Antithrombin Therapy. Biomarkers in Medicine. 5(2). 211–218. 3 indexed citations
10.
Halim, Abdel‐Baset. (2009). Impact of Discrepant Results from Clinical Laboratories on Patients and Pharmaceutical Trials: Evidence From Proficiency Testing Results. Biomarkers in Medicine. 3(3). 231–238. 6 indexed citations
11.
Fraga, Daniel, Omaima M. Sabek, Agnes Lo, et al.. (2004). PRESERVATION OF HUMAN PANCREATIC ISLET IN VIVO FUNCTION AFTER 6-MONTH CULTURE IN SERUM-FREE MEDIA1. Transplantation. 77(8). 1147–1154. 19 indexed citations
12.
Halim, Abdel‐Baset, Hélène Legros, Margaret E. Chamberlin, Arthur M. Geller, & Malak Kotb. (2001). Distinct patterns of protein binding to the MAT2A promoter in normal and leukemic T cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1540(1). 32–42. 5 indexed citations
13.
Halim, Abdel‐Baset, Leighton LeGros, Arthur M. Geller, & Malak Kotb. (1999). Expression and Functional Interaction of the Catalytic and Regulatory Subunits of Human Methionine Adenosyltransferase in Mammalian Cells. Journal of Biological Chemistry. 274(42). 29720–29725. 82 indexed citations
14.
El-Ahmady, O., et al.. (1999). The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience.. PubMed. 19(4A). 2603–8. 10 indexed citations
15.
Halim, Abdel‐Baset, et al.. (1997). Biochemical Effect of Antioxidants on Lipids and Liver Function in Experimentally-Induced Liver Damage. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 34(6). 656–663. 109 indexed citations
16.
Dash, S., et al.. (1997). Transfection of HepG2 cells with infectious hepatitis C virus genome.. PubMed. 151(2). 363–73. 67 indexed citations
17.
Halim, Abdel‐Baset, et al.. (1994). Urinary β‐HCG in Benign and Malignant Urinary Tract Diseases. Disease Markers. 12(2). 109–115. 6 indexed citations
18.
Halim, Abdel‐Baset, et al.. (1993). Serum TPS versus TPA in Egyptian Bladder Cancer Patients. The International Journal of Biological Markers. 8(4). 221–226. 5 indexed citations
19.
Halim, Abdel‐Baset, et al.. (1992). Simultaneous Determination of Urinary CEA, Ferritin and TPA in Egyptian Bladder Cancer Patients. The International Journal of Biological Markers. 7(4). 234–239. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Xue Breakdown of academic impact, for papers by Qifan Zhang Breakdown of academic impact, for papers by Hiroyuki Muro Breakdown of academic impact, for papers by Jing Quan Lim Breakdown of academic impact, for papers by Jeanine Ward Breakdown of academic impact, for papers by Shinji Furuya Breakdown of academic impact, for papers by Nicola Gentiloni Breakdown of academic impact, for papers by Hidenari Nagai Breakdown of academic impact, for papers by Jiaqi Li
Rankless by CCL
2026